Sponsor

Polpharma Biologics S.A.

Poland Ul. Trzy Lipy 3, 80-172 Gdansk, Poland

About the sponsor

Research activity includes ulcerative colitis, with a focus on treatments for moderately to severely active disease and the evaluation of gastrointestinal inflammation in clinical settings.

Ulcerative colitis
Inflammatory bowel disease
Clinical response

The sponsor’s trial portfolio reflects interest in therapies used to manage persistent bowel inflammation and related symptom control.

About Specializations

Polpharma Biologics S.A. runs clinical trials in conditions such as Colitis ulcerative, among others.

Colitis ulcerative

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Vedolizumab
Sponsor:Polpharma Biologics S.A.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →